Your browser doesn't support javascript.
loading
Role of antiseptics in the prevention and treatment of infections in nursing homes.
Alves, P J; Gryson, L; Hajjar, J; Lepelletier, D; Reners, M; Rodríguez Salazar, J; Simon, A.
Afiliación
  • Alves PJ; Wounds Research Laboratory, Centre for Interdisciplinary Research in Health (CIIS), Universidade Católica Portuguesa, Portugal. Electronic address: pjalves@ucp.pt.
  • Gryson L; Belgian Defence Medical Component, Brussels, Belgium.
  • Hajjar J; Infection Control Practitioner, Consultant, Pau, France.
  • Lepelletier D; Hospital Hygiene Department, Nantes University Hospital, Nantes, France.
  • Reners M; Private Dental Practice, Liège, Belgium.
  • Rodríguez Salazar J; Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
  • Simon A; Infection Control Team, Groupe Hospitalier Jolimont, Haine Saint-Paul, Belgium.
J Hosp Infect ; 131: 58-69, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36216172
ABSTRACT
Inadequate infection control, wound care, and oral hygiene protocols in nursing homes pose challenges to residents' quality of life. Based on the outcomes from a focus group meeting and a literature search, this narrative review evaluates the current and potential roles of antiseptics within nursing home infection management procedures. We examine contemporary strategies and concerns within the management of meticillin-resistant Staphylococcus aureus (MRSA; including decolonization regimes), chronic wound care, and oral hygiene, and review the available data for the use of antiseptics, with a focus on povidone-iodine. Compared with chlorhexidine, polyhexanide, and silver, povidone-iodine has a broader spectrum of antimicrobial activity, with rapid and potent activity against MRSA and other microbes found in chronic wounds, including biofilms. As no reports of bacterial resistance or cross-resistance following exposure to povidone-iodine exist, it may be preferable for MRSA decolonization compared with mupirocin and chlorhexidine, which can lead to resistant MRSA strains. Povidone-iodine oral products have greater efficacy against oral pathogens compared with other antiseptics such as chlorhexidine mouthwash, highlighting the clinical benefit of povidone-iodine in oral care. Additionally, povidone-iodine-based products, including mouthwash, have demonstrated rapid in-vitro virucidal activity against SARS-CoV-2 and may help reduce its transmission if incorporated into nursing home coronavirus 2019 control protocols. Importantly, povidone-iodine activity is not adversely affected by organic material, such as that found in chronic wounds and the oral cavity. Povidone-iodine is a promising antiseptic agent for the management of infections in the nursing home setting, including MRSA decolonization procedures, chronic wound management, and oral care.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Staphylococcus aureus Resistente a Meticilina / COVID-19 / Antiinfecciosos Locales Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Staphylococcus aureus Resistente a Meticilina / COVID-19 / Antiinfecciosos Locales Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: J Hosp Infect Año: 2023 Tipo del documento: Article